UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The complete title: The effect of interleukin-28B rs12979860 polymorphism on the therapeutic response of Moroccan patients with chronic hepatitis C

Gene, 2015-08, Vol.568 (1), p.31-34

2015

Volltextzugriff (PDF)

Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report

Journal of medical case reports, 2020-05, Vol.14 (1), p.62-62, Article 62

2020

Volltextzugriff (PDF)

An evaluation of ledipasvir + sofosbuvir for the treatment of chronic hepatitis C infection

Expert opinion on pharmacotherapy, 2021-09, Vol.22 (14), p.1839-1846

2021

Volltextzugriff (PDF)

An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection

Clinical and molecular hepatology, 2019-12, Vol.25 (4), p.400

2019

Volltextzugriff (PDF)

만성 C형 간염 환자를 대상으로 한 Direct Acting Antiviral 병합 요법의 효과와 안정성: 단일기관 연구

The Korean journal of gastroenterology, 2018-10, Vol.72 (4), p.197

2018

Volltextzugriff (PDF)

The Impact of a Sustained Virologic Response to Hepatitis C Virus Treatment on Liver Stiffness in the Puerto Rico Veterans Attending Liver Clinics in the Veterans Affairs Caribbean Healthcare System

Puerto Rico health sciences journal, 2022-09, Vol.41 (3), p.123-127

2022

Volltextzugriff (PDF)

Effect of baseline resistance‐associated substitutions on the efficiency of glecaprevir/pibrentasvir in chronic hepatitis C subjects: A meta‐analysis

Journal of viral hepatitis, 2021-01, Vol.28 (1), p.177-185

2021

Volltextzugriff (PDF)

Immunological Characteristics of Patients Receiving Ultra-Short Treatment for Chronic Hepatitis C

Frontiers in cellular and infection microbiology, 2022-06, Vol.12, p.885824-885824

2022

Volltextzugriff (PDF)

Real-World Clinical Efficacy and Tolerability of Direct-Acting Antivirals in Hepatitis C Monoinfection Compared to Hepatitis C/Human Immunodeficiency Virus Coinfection in a Community Care Setting

Gut and liver, 2018-11, Vol.12 (6), p.694

2018

Volltextzugriff (PDF)

The Stepped Care Intervention to Suppress Viral Load in Youth Living With HIV: Protocol for a Randomized Controlled Trial

JMIR research protocols, 2019-02, Vol.8 (2), p.e10791-e10791

2019

Volltextzugriff (PDF)

Application of Exposure-Response Analyses to Establish the Pharmacodynamic Similarity of a Once-Daily Regimen to an Approved Twice-Daily Dosing Regimen for the Treatment of HCV Infection

The AAPS journal, 2017-09, Vol.19 (5), p.1523-1535

2017

Volltextzugriff (PDF)

Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients

World journal of gastroenterology : WJG, 2015-08, Vol.21 (29), p.8935-8942

2015

Volltextzugriff (PDF)

Glecaprevir + pibrentasvir (ABT493 + ABT-530) for the treatment of Hepatitis C

Expert review of gastroenterology & hepatology, 2018-01, Vol.12 (1), p.9-17

2018

Volltextzugriff (PDF)

HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patients

Journal of clinical virology, 2015-12, Vol.73, p.32-35

2015

Volltextzugriff (PDF)

The efficacy and safety of elbasvir/grazoprevir treatment in HCV genotype 1 patients in Taiwan

Journal of medical virology, 2020-02, Vol.92 (2), p.219-226

2020

Volltextzugriff (PDF)

Clinical Significance of Discordant Positive Hepatitis C Virus Transcription–Mediated Amplification Following End of Treatment Response

Digestive diseases and sciences, 2012, Vol.57 (1), p.239-242

2012

Volltextzugriff (PDF)

The Efficacy of 24-Week Interferon Monotherapy for Type C Liver Cirrhosis in Japanese Patients with Genotype 1b and Low Virus Load

Intervirology, 2008-01, Vol.51 (4), p.265-269

2008

Volltextzugriff (PDF)

Hepatic Fibrosis in Hepatitis C

Hepatitis C Virus II, p.79-108

Volltextzugriff (PDF)

Drug–drug interactions with direct‐acting antivirals: when do we need to care?

Clinical Dilemmas in Viral Liver Disease, 2020, p.86-93

2020

Volltextzugriff (PDF)

Reverse genetic tools to study hepatitis C virus

Reverse Genetics of RNA Viruses, 2012, p.64-90

Bridgen, Anne

2012

Volltextzugriff (PDF)

Shortened 8 Weeks Course of Dual Sofosbuvir/Daclatasvir Therapy in Adolescent Patients, With Chronic Hepatitis C Infection

Journal of pediatric gastroenterology and nutrition, 2018-03, Vol.66 (3), p.425-427

2018

Volltextzugriff (PDF)

Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels

Journal of hepatology, 2007-03, Vol.46 (3), p.403-410

2007

Volltextzugriff (PDF)

Interferon-λ polymorphisms and response to pegylatedinterferon in Iranian hepatitis C patients

世界胃肠病学杂志：英文版（电子版）, 2015 (29), p.8935-8942

2015

Volltextzugriff (PDF)

How to optimize HCV therapy in genotype 1 patients with cirrhosis

Liver international, 2013-02, Vol.33 (s1), p.46-55

2013

Volltextzugriff (PDF)

Treatment strategies for chronic hepatitis C prior to andfollowing liver transplantation

世界肝病学杂志：英文版（电子版）, 2016 (1), p.69-73

2016

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

ThemaSustained Virologic Response

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(30)
Buchkapitel
(4)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The complete title: The effect of interleukin-28B rs12979860 polymorphism on the therapeutic response of Moroccan patients with chronic hepatitis C

Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report

An evaluation of ledipasvir + sofosbuvir for the treatment of chronic hepatitis C infection

An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection

만성 C형 간염 환자를 대상으로 한 Direct Acting Antiviral 병합 요법의 효과와 안정성: 단일기관 연구

The Impact of a Sustained Virologic Response to Hepatitis C Virus Treatment on Liver Stiffness in the Puerto Rico Veterans Attending Liver Clinics in the Veterans Affairs Caribbean Healthcare System

Effect of baseline resistance‐associated substitutions on the efficiency of glecaprevir/pibrentasvir in chronic hepatitis C subjects: A meta‐analysis

Immunological Characteristics of Patients Receiving Ultra-Short Treatment for Chronic Hepatitis C

Real-World Clinical Efficacy and Tolerability of Direct-Acting Antivirals in Hepatitis C Monoinfection Compared to Hepatitis C/Human Immunodeficiency Virus Coinfection in a Community Care Setting

The Stepped Care Intervention to Suppress Viral Load in Youth Living With HIV: Protocol for a Randomized Controlled Trial

Application of Exposure-Response Analyses to Establish the Pharmacodynamic Similarity of a Once-Daily Regimen to an Approved Twice-Daily Dosing Regimen for the Treatment of HCV Infection

Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients

Glecaprevir + pibrentasvir (ABT493 + ABT-530) for the treatment of Hepatitis C

HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patients

The efficacy and safety of elbasvir/grazoprevir treatment in HCV genotype 1 patients in Taiwan

Clinical Significance of Discordant Positive Hepatitis C Virus Transcription–Mediated Amplification Following End of Treatment Response

The Efficacy of 24-Week Interferon Monotherapy for Type C Liver Cirrhosis in Japanese Patients with Genotype 1b and Low Virus Load

Hepatic Fibrosis in Hepatitis C

Drug–drug interactions with direct‐acting antivirals: when do we need to care?

Reverse genetic tools to study hepatitis C virus

Shortened 8 Weeks Course of Dual Sofosbuvir/Daclatasvir Therapy in Adolescent Patients, With Chronic Hepatitis C Infection

Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels

Interferon-λ polymorphisms and response to pegylatedinterferon in Iranian hepatitis C patients

How to optimize HCV therapy in genotype 1 patients with cirrhosis

Treatment strategies for chronic hepatitis C prior to andfollowing liver transplantation

Aktive Filter

Suchergebnisse filtern